Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies

Abstract:  Melatonin is an endogenous indoleamine, produced mainly by the pineal gland. Melatonin has been proven to have chronobiotic, antioxidant, antihypertensive, anxiolytic and sedative properties. There are also experimental and clinical data supporting an analgesic role of melatonin. In experimental studies, melatonin shows potent analgesic effects in a dose‐dependent manner. In clinical studies, melatonin has been shown to have analgesic benefits in patients with chronic pain (fibromyalgia, irritable bowel syndrome, migraine). The physiologic mechanism underlying the analgesic actions of melatonin has not been clarified. The effects may be linked to Gi‐coupled melatonin receptors, to Gi‐coupled opioid μ‐receptors or GABA‐B receptors with unknown downstream changes with a consequential reduction in anxiety and pain. Also, the repeated administration of melatonin improves sleep and thereby may reduce anxiety, which leads to lower levels of pain. In this paper, we review the current evidence regarding the analgesic properties of melatonin in animals and humans with chronic pain.

[1]  F. Gorial,et al.  Adjuvant use of melatonin for treatment of fibromyalgia , 2011, Journal of pineal research.

[2]  M. Abdollahi,et al.  Implications of melatonin therapy in irritable bowel syndrome: a systematic review. , 2010, Current pharmaceutical design.

[3]  E. Seet,et al.  Efficacy and Safety of Melatonin as an Anxiolytic and Analgesic in the Perioperative Period: A Qualitative Systematic Review of Randomized Trials , 2010, Anesthesiology.

[4]  L. Fuentes-Broto,et al.  Gastrointestinal tract and melatonin: Reducing pathophysiology , 2010 .

[5]  R. Reiter,et al.  Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease , 2010, Journal of pineal research.

[6]  A. Domínguez-Rodríguez,et al.  Melatonin and circadian biology in human cardiovascular disease , 2010, Journal of pineal research.

[7]  R. Reiter,et al.  Melatonin protects against isoproterenol‐induced myocardial injury in the rat: antioxidative mechanisms , 2010, Journal of pineal research.

[8]  C. Chiao,et al.  Visualization of melatonin’s multiple mitochondrial levels of protection against mitochondrial Ca2+‐mediated permeability transition and beyond in rat brain astrocytes , 2010, Journal of pineal research.

[9]  V. Cassone,et al.  Pineal melatonin acts as a circadian zeitgeber and growth factor in chick astrocytes , 2009, Journal of pineal research.

[10]  M. J. Jarzynka,et al.  Microtubules modulate melatonin receptors involved in phase‐shifting circadian activity rhythms: in vitro and in vivo evidence , 2009, Journal of pineal research.

[11]  T. Minett,et al.  Low urinary 6-sulphatoxymelatonin concentrations in acute migraine , 2008, The Journal of Headache and Pain.

[12]  T. Brzozowski,et al.  Role of melatonin in upper gastrointestinal tract. , 2007, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[13]  G. Pasternak.  When it comes to opiates, just say NO. , 2007, The Journal of clinical investigation.

[14]  R. Reiter,et al.  Melatonin therapy in fibromyalgia , 2007, Current pain and headache reports.

[15]  Qiang Chen,et al.  Melatonin attenuates the development of antinociceptive tolerance to delta-, but not to mu-opioid receptor agonist in mice , 2007, Behavioural Brain Research.

[16]  C. Delaney,et al.  Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection. , 2007, Journal of the American College of Surgeons.

[17]  R. Reiter,et al.  Therapeutic Effect of Melatonin in Patients With Functional Dyspepsia , 2007, Journal of clinical gastroenterology.

[18]  S. Malhotra,et al.  A Preliminary Study of Melatonin in Irritable Bowel Syndrome , 2007, Journal of clinical gastroenterology.

[19]  P. Phansuwan-Pujito,et al.  Melatonin inhibits cortical spreading depression-evoked trigeminal nociception , 2006, Neuroreport.

[20]  M. Kaster,et al.  Mechanisms involved in the antinociception caused by melatonin in mice , 2006, Journal of pineal research.

[21]  R. Coleman,et al.  A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy. , 2006, American journal of obstetrics and gynecology.

[22]  Ya-li Peng,et al.  Effects of melatonin on orphanin FQ/nociceptin-induced hyperalgesia in mice , 2006, Brain Research.

[23]  F. Ozyigit,et al.  Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: Possible involvements of the L-arginine-NO pathway and opioid system. , 2006, Life sciences.

[24]  E. Viscusi,et al.  Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery , 2006, Surgical Endoscopy And Other Interventional Techniques.

[25]  B. Padhy,et al.  Inhibition of Calotropis procera Latex-Induced Inflammatory Hyperalgesia by Oxytocin and Melatonin , 2005, Mediators of inflammation.

[26]  K. Gwee,et al.  Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double‐blind placebo‐controlled study , 2005, Alimentary pharmacology & therapeutics.

[27]  P. Mease,et al.  Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. , 2005, The Journal of rheumatology. Supplement.

[28]  A. Rodrigues,et al.  Mechanisms involved in the antinociception caused by agmatine in mice , 2005, Neuropharmacology.

[29]  K. Ho,et al.  Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study , 2005, Gut.

[30]  Qiang Chen,et al.  Melatonin enhances antinociceptive effects of δ-, but not μ-opioid agonist in mice , 2005, Brain Research.

[31]  H. Redmond,et al.  Effects of a selective cyclo‐oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity , 2004, The British journal of surgery.

[32]  J. Cipolla-Neto,et al.  Melatonin, 3 mg, is effective for migraine prevention , 2004, Neurology.

[33]  C. Porro,et al.  Diurnal changes of tonic nociceptive responses in mice: evidence for a proalgesic role of melatonin , 2004, Pain.

[34]  W. Willis,et al.  Effects of intrathecal injections of melatonin analogs on capsaicin-induced secondary mechanical allodynia and hyperalgesia in rats , 2004, Pain.

[35]  R. Noseda,et al.  Melatonin-induced inhibition of spinal cord synaptic potentiation in rats is MT2 receptor-dependent , 2004, Neuroscience Letters.

[36]  P. Mediratta,et al.  Evaluation of the role of melatonin in formalin-induced pain response in mice. , 2004, Indian journal of medical sciences.

[37]  G. Spadoni,et al.  The Hypnotic and Analgesic Effects of 2-Bromomelatonin , 2003, Anesthesia and analgesia.

[38]  E. Speckmann,et al.  Gene expression and functional characterization of melatonin receptors in the spinal cord of the rat: implications for pain modulation , 2003, Journal of pineal research.

[39]  P. Schmid,et al.  Pharmacological effects of intravenous melatonin: comparative studies with thiopental and propofol. , 2003, British journal of anaesthesia.

[40]  M. Ebadi,et al.  The presence of delta and mu-, but not kappa or ORL1 receptors in bovine pinealocytes , 2002, Brain Research.

[41]  S. El-Shenawy,et al.  Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat. , 2002, Pharmacological research.

[42]  J. Jacobs,et al.  Evaluation and management of endocrine dysfunction in fibromyalgia. , 2002, Rheumatic diseases clinics of North America.

[43]  J. Gagnier.  The therapeutic potential of melatonin in migraines and other headache types. , 2001, Alternative medicine review : a journal of clinical therapeutic.

[44]  E N Brown,et al.  Circadian rhythms of women with fibromyalgia. , 2001, The Journal of clinical endocrinology and metabolism.

[45]  M. Capogna,et al.  The effects of GABAB agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat , 2001, Pain.

[46]  Y. Dauvilliers,et al.  Le sommeil du fibromyalgique : revue des données cliniques et polygraphiques , 2001, Neurophysiologie Clinique/Clinical Neurophysiology.

[47]  S. F. Tsang,et al.  Effects of melatonin, morphine and diazepam on formalin-induced nociception in mice. , 2001, Life sciences.

[48]  S. Kulkarni,et al.  Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. , 2000, European journal of pharmacology.

[49]  S. Tufik,et al.  Randomized, double‐blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment , 2000, Journal of pineal research.

[50]  Xiao-ding Cao,et al.  The analgesic effects of peripheral and central administration of melatonin in rats. , 2000, European journal of pharmacology.

[51]  S. Kulkarni,et al.  Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice. , 2000, European journal of pharmacology.

[52]  Xiao-ding Cao,et al.  Selective MT2 melatonin receptor antagonist blocks melatonin-induced antinociception in rats , 2000, Neuroscience Letters.

[53]  M. Demitrack,et al.  Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. , 1999, The Journal of rheumatology.

[54]  S. Enna,et al.  Nociceptive regulation of GABAB receptor gene expression in rat spinal cord , 1999, Neuropharmacology.

[55]  L. Wetterberg,et al.  Fibromyalgia — a syndrome associated with decreased nocturnal melatonin secretion , 1998, Clinical endocrinology.

[56]  R. Reiter,et al.  Pineal opioid receptors and analgesic action of melatonin , 1998, Journal of pineal research.

[57]  M. Phillip,et al.  Normal melatonin levels in patients with fibromyalgia syndrome. , 1998, The Journal of rheumatology.

[58]  G. Chazot,et al.  Nocturnal Plasma Melatonin Profile and Melatonin Kinetics During Infusion in Status Migrainosus , 1997, Cephalalgia : an international journal of headache.

[59]  D. Cardinali,et al.  Melatonin Effects on Behavior: Possible Mediation by the Central GABAergic System , 1996, Neuroscience & Biobehavioral Reviews.

[60]  G. Chazot,et al.  Nocturnal Melatonin Excretion is Decreased in Patients With Migraine Without Aura Attacks Associated With Menses , 1995, Cephalalgia : an international journal of headache.

[61]  H. Jick,et al.  Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs , 1994, The Lancet.

[62]  João Batista de Sousa,et al.  Effects of diclofenac sodium on intestinal anastomotic healing , 1991, Diseases of the colon and rectum.

[63]  J. Glowinski,et al.  Mu and delta opiate receptors coupled negatively to adenylate cyclase on embryonic neurons from the mouse striatum in primary cultures , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[64]  D. Sugden.  Psychopharmacological effects of melatonin in mouse and rat. , 1983, The Journal of pharmacology and experimental therapeutics.

[65]  M. Camilleri,et al.  Irritable Bowel Syndrome , 2012, Drugs.

[66]  T. Peng,et al.  Visualization of Melatonin's Multiple Mitochondrial Levels of Protection Against Mitochondrial Ca2+-Mediated Permeability Transition and Beyond in Rat Brain Astrocytes , 2010 .

[67]  M. Camilleri,et al.  Irritable bowel syndrome: recent and novel therapeutic approaches. , 2006, Drugs.

[68]  Qiang Chen,et al.  Melatonin enhances antinociceptive effects of delta-, but not mu-opioid agonist in mice. , 2005, Brain research.

[69]  J. Touchon,et al.  [Sleep in fibromyalgia: review of clinical and polysomnographic data]. , 2001, Neurophysiologie clinique = Clinical neurophysiology.

[70]  M. A. Arias,et al.  The Effect of Melatonin in Patients with Fibromyalgia: A Pilot Study , 2000, Clinical Rheumatology.

[71]  T. Koyama,et al.  Functional coupling of GABAB receptors with G proteins that are sensitive to N-ethylmaleimide treatment, suramin, and benzalkonium chloride in rat cerebral cortical membranes , 2000, Journal of Neural Transmission.

[72]  A. Drosos,et al.  Treatment of Fibromyalgia with Tropisetron, a 5HT3 Serotonin Antagonist: A Pilot Study , 2000, Clinical Rheumatology.

[73]  S. Enna,et al.  Nociceptive regulation of GABA(B) receptor gene expression in rat spinal cord. , 1999, Neuropharmacology.

[74]  N. Osborne,et al.  Pertussis toxin-sensitive melatonin receptors negatively coupled to adenylate cyclase associated with cultured human and rat retinal pigment epithelial cells. , 1995, Investigative ophthalmology & visual science.

[75]  K. Saito,et al.  Effect of neurotropin on hyperalgesia induced by prostaglandin E2, naloxone, melatonin and dark condition in mice. , 1987, Japanese journal of pharmacology.